SOURCE: Cutting Edge Information

Cutting Edge Information

February 16, 2016 09:00 ET

Global Sales for New Formulations Range Between $65 Million and $8 Billion Annually Among Surveyed Companies

Despite Significant Costs, Forty-Five Percent of Surveyed Companies Use New Formulations as a Line Extension Strategy, According to Cutting Edge Information

RESEARCH TRIANGLE PARK, NC--(Marketwired - February 16, 2016) - Although deciding on a new formulation as a way to extend a product line requires significant investment, this lifecycle management (LCM) strategy can also yield significant returns. Global sales for new formulations range from $65 million to $8 billion among surveyed companies, according to primary intelligence provider Cutting Edge Information.

Forty-five percent of surveyed companies in Pharmaceutical Lifecycle Management: Expand and Extend Portfolio Value with a Well-Integrated LCM Strategy leverage new formulations as a line extension strategy, making it the second most popular lifecycle tactic among surveyed teams. A new formulation is costly and time-consuming, as additional clinical trials must be performed to prove the safety and efficacy of the new product. However, new formulation tactics have proven highly effective.

"A team with a successful brand can gain a lot by investing in a new formulation," said Natalie DeMasi, senior analyst at Cutting Edge Information. "With global sales for new formulations among surveyed companies ranging from $65 million to $8 billion annually, life sciences groups stand to gain a lot by considering this LCM strategy."

Pharmaceutical Lifecycle Management: Expand and Extend Portfolio Value with a Well-Integrated LCM Strategy, available at, includes detailed metrics and case studies for 14 different lifecycle management strategies, such as new formulations, new dosages, combination products and next-generation products. Metrics include average implementation costs, average return-on-investment, timelines for planning and executing each tactic, as well as primary goals for implementing each strategy.

LCM teams can use this report to understand how top life science companies:

  • Build a robust LCM strategy by combining market enhancement and line extension tactics
  • Create a dedicated LCM team and cross-functional committee to develop the most effective lifecycle management plans
  • Implement strong leadership to ensure a successful LCM strategy
  • Generate excitement with cost-effective publications strategies
  • Invest in next-generation drug development to yield large returns

To learn more about Cutting Edge Information and its research report offerings, please visit

Image Available:

Contact Information